Research and development expenses were $5,200,000 compared to $6,600,000 in the prior year period and $5,000,000 in the prior quarter. Selling, general and administrative expenses were $3,000,000 in the quarter ended June 30, 2023, compared to $2,700,000 in the prior year quarter and $1,900,000 in the previous quarter. We that through June 30, 2023, we have incurred research and development spending in excess of $140,000,000 on our APU product offering. Q1 fiscal 2024 operating loss was $5,100,000 compared to an operating loss of $3,900,000 in the prior year period and an operating loss of $3,900,000 in the prior quarter. Q1 fiscal 2024 net loss included interest and other income of $80,000 and a tax provision of $51,000 compared to $26,000 in interest, other expense and a tax provision of $60,000 for the same a year ago.